home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Targeted Cancer Therapies

 
  June 27, 2006  
     
 
Cambridge Healthtech Institute, Cambridge, Massachusetts
August, 21 - 22, 2006


Sessions Include:

Biomarkers and Surrogates
Tumor Targeting and Validation
Fully Human Monoclonal Antibodies
New Targets
Immunomodulators/Adjuvants
Autologus Cell Technologies

detailed program on website

 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Keynote Presentations:
Misguiding Cues used by Viruses to Thwart Protective Immunity:Lessons for Tumor Immunity
Ellis L. Reinherz MD, Professor of Medicine, Harvard Medical School; Director, Cancer Vaccine Center and Chief, Laboratory of Immunobiology, Dana Farber Cancer Institute, USA

New Vaccine Technologies: A Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory Review
Officer, Office of Vaccines Research and Review, CBER/FDA

Featured Speaker:

Adjuvanting DNA Vaccines
David B. Weiner, Ph.D., Chair, Gene Therapy and Vaccines Program, CAMB, Department of Pathology, University of Pennsylvania School of Medicine

more speakers and detailed program on website

 
Deadline for Abstracts: July 31 for poster presentations
 
Registration: online registration available
E-mail: meder@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.